ImmuCell Corporation (ICCC) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

ImmuCell Corporation (ICCC) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $96.2M, listed on NASDAQ, employing roughly 69 people, carrying a beta of 0.50 to the broader market. ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. Led by F. Olivier Te Boekhorst, public since 1987-05-05.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for ICCC as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →